Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 925171, 14 pages
http://dx.doi.org/10.1155/2013/925171
Research Article

Activation of TRPV1 Prevents OxLDL-Induced Lipid Accumulation and TNF-α-Induced Inflammation in Macrophages: Role of Liver X Receptor α

1Department of Physiology, School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
2Division of Cardiology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei 11221, Taiwan
3Heart Center, Cheng-Hsin General Hospital, Taipei 11221, Taiwan
4Cardiovascular Division, Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan

Received 15 April 2013; Accepted 26 May 2013

Academic Editor: Ishak Tekin

Copyright © 2013 Jin-Feng Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Glass and J. L. Witztum, “Atherosclerosis: the road ahead,” Cell, vol. 104, no. 4, pp. 503–516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Riccioni, A. Zanasi, N. Vitulano, B. Mancini, and N. D'Orazio, “Leukotrienes in atherosclerosis: new target insights and future therapy perspectives,” Mediators of Inflammation, vol. 2009, Article ID 737282, 6 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. C. Li and C. K. Glass, “The macrophage foam cell as a target for therapeutic intervention,” Nature Medicine, vol. 8, no. 11, pp. 1235–1242, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Monaco, J. E. Cole, and E. Georgiou, “The expression and functions of toll-like receptors in atherosclerosis,” Mediators of Inflammation, vol. 2010, Article ID 393946, 18 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. V. V. Kunjathoor, M. Febbraio, E. A. Podrez et al., “Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages,” The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49982–49988, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. O. Rahaman, D. J. Lennon, M. Febbraio, E. A. Podrez, S. L. Hazen, and R. Silverstein, “A CD36-dependent signaling cascade is necessary for macrophage foam cell formation,” Cell Metabolism, vol. 4, no. 3, pp. 211–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Van Eck, I. S. T. Bos, R. B. Hildebrand, B. T. Van Rij, and T. J. C. Van Berkel, “Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development,” American Journal of Pathology, vol. 165, no. 3, pp. 785–794, 2004. View at Google Scholar · View at Scopus
  8. C. W. Joyce, M. J. A. Amar, G. Lambert et al., “The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 407–412, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-Y. Lin, T.-S. Lee, C.-C. Chen et al., “Endothelin-1 exacerbates lipid accumulation by increasing the protein degradation of the ATP-binding cassette transporter G1 in macrophages,” Journal of Cellular Physiology, vol. 226, no. 8, pp. 2198–2205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T.-S. Lee, C.-Y. Lin, J.-Y. Tsai et al., “Resistin increases lipid accumulation by affecting class A scavenger receptor, CD36 and ATP-binding cassette transporter-A1 in macrophages,” Life Sciences, vol. 84, no. 3-4, pp. 97–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J.-Y. Tsai, K.-H. Su, S.-K. Shyue et al., “EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1,” Cardiovascular Research, vol. 88, no. 3, pp. 415–423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. K.-Y. Lu, L.-C. Ching, K.-H. Su et al., “Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor α,” Circulation, vol. 121, no. 16, pp. 1828–1837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Sorrentino, S. Morello, S. Chen, E. Bonavita, and A. Pinto, “The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation,” Journal of Cellular Physiology, vol. 223, no. 1, pp. 158–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Venkatachalam and C. Montell, “TRP channels,” Annual Review of Biochemistry, vol. 76, pp. 387–417, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Caterina, M. A. Schumacher, M. Tominaga, T. A. Rosen, J. D. Levine, and D. Julius, “The capsaicin receptor: a heat-activated ion channel in the pain pathway,” Nature, vol. 389, no. 6653, pp. 816–824, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Holzer, “Acid sensing by visceral afferent neurones,” Acta Physiologica, vol. 201, no. 1, pp. 63–75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Van Der Stelt and V. Di Marzo, “Endovanilloids: putative endogenous ligands of transient receptor potential vanilloid 1 channels,” European Journal of Biochemistry, vol. 271, no. 10, pp. 1827–1834, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. L.-Y. Lee and Q. Gu, “Role of TRPV1 in inflammation-induced airway hypersensitivity,” Current Opinion in Pharmacology, vol. 9, no. 3, pp. 243–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. de Petrocellis, P. Orlando, A. S. Moriello et al., “Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation,” Acta Physiologica, vol. 204, no. 2, pp. 255–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. L. V. Pearce, P. A. Petukhov, T. Szabo et al., “Evodiamine functions as an agonist for the vanilloid receptor TRPV1,” Organic & Biomolecular Chemistry, vol. 2, no. 16, pp. 2281–2286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. C. Thomas, M. Ethirajan, K. Shahrokh et al., “Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity,” Journal of Pharmacology and Experimental Therapeutics, vol. 337, no. 2, pp. 400–410, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Golech, R. M. McCarron, Y. Chen et al., “Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors,” Molecular Brain Research, vol. 132, no. 1, pp. 87–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Yao and C. J. Garland, “Recent developments in vascular endothelial cell transient receptor potential channels,” Circulation Research, vol. 97, no. 9, pp. 853–863, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. R. L. Baylie and J. E. Brayden, “TRPV channels and vascular function,” Acta Physiologica, vol. 203, no. 1, pp. 99–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Yang, Z. Luo, S. Ma et al., “Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension,” Cell Metabolism, vol. 12, no. 2, pp. 130–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Wang and D. H. Wang, “TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice,” Circulation, vol. 112, no. 23, pp. 3617–3623, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. L.-C. Ching, Y. R. Kou, S.-K. Shyue et al., “Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1,” Cardiovascular Research, vol. 91, no. 3, pp. 492–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Mbalaviele, Y. Abu-Amer, A. Meng et al., “Activation of peroxisome proliferator-activated receptor-γ pathway inhibits osteoclast differentiation,” The Journal of Biological Chemistry, vol. 275, no. 19, pp. 14388–14393, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. B. F. Asztalos, M. de la Llera-Moya, G. E. Dallal, K. V. Horvath, E. J. Schaefer, and G. H. Rothblat, “Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux,” Journal of Lipid Research, vol. 46, no. 10, pp. 2246–2253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. L.-C. Cheng, K.-H. Su, Y. R. Kou et al., “α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1,” Free Radical Biology and Medicine, vol. 50, no. 1, pp. 47–54, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Deng, L. Zhang, Y. Ge, M. Lu, and X. Zheng, “Redistribution of intracellular calcium and its effect on apoptosis in macrophages: induction by oxidized LDL,” Biomedicine and Pharmacotherapy, vol. 63, no. 4, pp. 267–274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Febbraio, E. A. Podrez, J. D. Smith et al., “Targeted disruption of the class B, scavenger receptor CD36 protects against atherosclerotic lesion development in mice,” The Journal of Clinical Investigation, vol. 105, no. 8, pp. 1049–1056, 2000. View at Google Scholar · View at Scopus
  34. C. Cavelier, I. Lorenzi, L. Rohrer, and A. von Eckardstein, “Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1,” Biochimica et Biophysica Acta, vol. 1761, no. 7, pp. 655–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. D. L. Silver, X.-C. Jiang, T. Arai, C. Bruce, and A. R. Tall, “Receptors and lipid transfer proteins in HDL metabolism,” Annals of the New York Academy of Sciences, vol. 902, pp. 103–112, 2000. View at Google Scholar · View at Scopus
  36. L. Yvan-Charvet, M. Ranalletta, N. Wang et al., “Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice,” The Journal of Clinical Investigation, vol. 117, no. 12, pp. 3900–3908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Hasegawa, S. Wakino, T. Kanda et al., “Divergent action of calcium channel blockers on ATP-binding cassette protein expression,” Journal of Cardiovascular Pharmacology, vol. 46, no. 6, pp. 787–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Iwamoto, R. Lu, N. Tanaka, S. Abe-Dohmae, and S. Yokoyama, “Calmodulin interacts with ATP binding cassette transporter A1 to protect from calpain-mediated degradation and upregulates high-density lipoprotein generation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 7, pp. 1446–1452, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. F. Zhao, L. C. Ching, Y. C. Huang et al., “Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis,” Molecular Nutrition & Food Research, vol. 56, pp. 691–701, 2012. View at Google Scholar
  40. S. Soumian, C. Albrecht, A. H. Davies, and R. G. J. Gibbs, “ABCA1 and atherosclerosis,” Vascular Medicine, vol. 10, no. 2, pp. 109–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Brooks-Wilson, M. Marcil, S. M. Clee et al., “Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency,” Nature Genetics, vol. 22, no. 4, pp. 336–345, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Bodzioch, E. Orsó, J. Klucken et al., “The gene encoding ATP-binding cassette transporter I is mutated in Tangier disease,” Nature Genetics, vol. 22, no. 4, pp. 347–351, 1999. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Zhu, J.-Y. Lee, J. M. Timmins et al., “Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages,” The Journal of Biological Chemistry, vol. 283, no. 34, pp. 22930–22941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Malik, S. Z. Berisha, J. Santore, C. Agatisa-Boyle, G. Brubaker, and J. D. Smith, “Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport,” Journal of Lipid Research, vol. 52, no. 5, pp. 951–957, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. C. McGillicuddy, M. de la Llera Moya, C. C. Hinkle et al., “Inflammation impairs reverse cholesterol transport in vivo,” Circulation, vol. 119, no. 8, pp. 1135–1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Castrillo, S. B. Joseph, S. A. Vaidya et al., “Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism,” Molecular Cell, vol. 12, no. 4, pp. 805–816, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. S. B. Joseph, M. N. Bradley, A. Castrillo et al., “LXR-dependent gene expression is important for macrophage survival and the innate immune response,” Cell, vol. 119, no. 2, pp. 299–309, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. S. B. Joseph, A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz, “Reciprocal regulation of inflammation and lipid metabolism by liver X receptors,” Nature Medicine, vol. 9, no. 2, pp. 213–219, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Tsuji, M. Murai, K. Oki et al., “Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents,” European Journal of Pharmacology, vol. 627, no. 1–3, pp. 332–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. J.-H. Kang, G. Tsuyoshi, I.-S. Han, T. Kawada, Y. M. Kim, and R. Yu, “Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet,” Obesity, vol. 18, no. 4, pp. 780–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Alawi and J. Keeble, “The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation,” Pharmacology & Therapeutics, vol. 125, no. 2, pp. 181–195, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. W.-F. Chiou, Y.-J. Sung, J.-F. Liao, A. Y.-C. Shum, and C.-F. Chen, “Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages,” Journal of Natural Products, vol. 60, no. 7, pp. 708–711, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Wang, Y. Wang, and H. Yamashita, “Evodiamine inhibits adipogenesis via the EGFR-PKCα-ERK signaling pathway,” FEBS Letters, vol. 583, no. 22, pp. 3655–3659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Hu, H. Fahmy, J. K. Zjawiony, and G. E. Davies, “Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation,” Fitoterapia, vol. 81, no. 4, pp. 259–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Ma, J. Zhong, Z. Zhao et al., “Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis,” Cardiovascular Research, vol. 92, no. 3, pp. 504–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. L. C. Ching, C. Y. Chen, K. H. Su et al., “Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase,” Molecular Medicine, vol. 18, no. 1, pp. 805–815, 2012. View at Google Scholar
  57. J. Wei, L. C. Ching, J. F. Zhao et al., “Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis,” Acta Physiologica, vol. 207, no. 2, pp. 299–307, 2013. View at Google Scholar
  58. L. Li, J. Chen, Y. Ni et al., “TRPV1 activationn prevents nonalcoholic fatty liver through UCP2 upregulation in mice,” Pflügers Archiv, vol. 463, no. 5, pp. 727–732, 2012. View at Google Scholar
  59. L. L. Zhang, D. Y. Liu, L. Q. Ma et al., “Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity,” Circulation Research, vol. 100, no. 7, pp. 1063–1070, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Wittenburg and M. C. Carey, “Biliary cholesterol secretion by the twinned sterol half-transporters ABCG5 and ABCG8,” The Journal of Clinical Investigation, vol. 110, no. 5, pp. 605–609, 2002. View at Publisher · View at Google Scholar · View at Scopus